Cevimeline and Mupirocin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cevimeline (cevimeline hydrochloride) and Mupirocin (mupirocin). Common drug interactions include asthma among females and malaise among males.

The phase IV clinical study analyzes what interactions people have when they take Cevimeline and Mupirocin. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Cevimeline?

Cevimeline has active ingredients of cevimeline hydrochloride. It is often used in sjogren syndrome. eHealthMe is studying from 1,480 Cevimeline users. Check the latest studies of Cevimeline.

What is Mupirocin?

Mupirocin has active ingredients of mupirocin. It is often used in impetigo. eHealthMe is studying from 5,940 Mupirocin users. Check the latest studies of Mupirocin.

On Jul, 15, 2026

16 people who take Cevimeline and Mupirocin together, and have interactions are studied.

Cevimeline and Mupirocin drug interactions.

What are the common drug interactions of Cevimeline and Mupirocin, by gender? *:

female:

Asthma
Dyspnoea (difficult or laboured respiration)
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
Erythema (redness of the skin)
Malaise (a feeling of general discomfort or uneasiness)
Postural orthostatic tachycardia syndrome (abnormal increase in heart rate on becoming upright)
Skin reaction
Stiff person syndrome
Weight decreased
Sepsis (a severe blood infection that can lead to organ failure and death)

male:

Malaise (a feeling of general discomfort or uneasiness)
Sensory loss (senses loss)
Spinal stenosis (narrowing of spinal column)
Abdominal discomfort
Dyspnoea (difficult or laboured respiration)
Epistaxis (bleed from the nose)
Eye discharge
Injection site bruising
Muscle spasms (muscle contraction)
Somnolence (a state of near-sleep, a strong desire for sleep)

What are the common drug interactions of Cevimeline and Mupirocin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Abdominal discomfort
Dyspnoea (difficult or laboured respiration)
Epistaxis (bleed from the nose)
Eye discharge
Injection site bruising
Muscle spasms (muscle contraction)
Somnolence (a state of near-sleep, a strong desire for sleep)

40-49:

Asthma
Dyspnoea (difficult or laboured respiration)
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
Erythema (redness of the skin)
Impaired gastric emptying
Malaise (a feeling of general discomfort or uneasiness)
Myasthenia gravis (a chronic condition that causes muscles to tire and weaken easily)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Postural orthostatic tachycardia syndrome (abnormal increase in heart rate on becoming upright)
Sepsis (a severe blood infection that can lead to organ failure and death)

50-59:

Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Sinusitis (inflammation of sinus)

60+:

Abdominal pain lower
Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
Pneumonia
Sepsis (a severe blood infection that can lead to organ failure and death)
Infection
Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
Lung hyperinflation (inspiration of more than normal)
Malaise (a feeling of general discomfort or uneasiness)
Nausea (feeling of having an urge to vomit)
Vomiting

What are the existing conditions these people have? *

Immune System Disorder: 5 people, 31.25%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 18.75%
Nasal Polyps (masses that develop in the lining of the nose): 2 people, 12.50%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 12.50%
Amyloidosis (a tumour within which amyloid is produced): 2 people, 12.50%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 6.25%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 6.25%
Asthma: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Cevimeline and Mupirocin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously